Sylvia Olofsson
Overview
Explore the profile of Sylvia Olofsson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
630
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Steg P, James S, Harrington R, Ardissino D, Becker R, Cannon C, et al.
Circulation
. 2010 Nov;
122(21):2131-41.
PMID: 21060072
Background: Aspirin and clopidogrel are recommended for patients with acute coronary syndromes (ACS) or undergoing coronary stenting. Ticagrelor, a reversible oral P2Y12-receptor antagonist, provides faster, greater, and more consistent platelet...
2.
Eggers K, Kempf T, Lagerqvist B, Lindahl B, Olofsson S, Jantzen F, et al.
Circ Cardiovasc Genet
. 2010 Feb;
3(1):88-96.
PMID: 20160200
Background: Growth-differentiation factor-15 (GDF-15) has emerged as a prognostic biomarker in patients with non-ST-segment-elevation acute coronary syndrome. This study assessed the time course and the long-term prognostic relevance of GDF-15...
3.
Snellman G, Melhus H, Gedeborg R, Olofsson S, Wolk A, Pedersen N, et al.
PLoS One
. 2009 Nov;
4(11):e7747.
PMID: 19915719
Background: Although environmental factors, mainly nutrition and UV-B radiation, have been considered major determinants of vitamin D status, they have only explained a modest proportion of the variation in serum...
4.
Lind L, Wallentin L, Kempf T, Tapken H, Quint A, Lindahl B, et al.
Eur Heart J
. 2009 Jun;
30(19):2346-53.
PMID: 19561023
Aims: Growth-differentiation factor-15 (GDF-15) is emerging as an independent prognostic biomarker in patients with cardiovascular (CV) disease. Little is known about the pathophysiological basis for the close association of GDF-15...
5.
Varenhorst C, James S, Erlinge D, Braun O, Brandt J, Winters K, et al.
Am Heart J
. 2009 Mar;
157(3):562.e1-9.
PMID: 19249429
Background: Variability in response to thienopyridines has led to the development of point-of-care devices to assess adenosine diphosphate (ADP)-induced platelet aggregation. These tests need to be evaluated in comparison to...
6.
Kempf T, Bjorklund E, Olofsson S, Lindahl B, Allhoff T, Peter T, et al.
Eur Heart J
. 2007 Nov;
28(23):2858-65.
PMID: 17977844
Aims: Growth-differentiation factor-15 (GDF-15) is a transforming growth factor-beta-related cytokine that is induced in the heart following ischaemia-reperfusion injury. We explored the prognostic utility of GDF-15 in patients with ST-segment...
7.
Wollert K, Kempf T, Lagerqvist B, Lindahl B, Olofsson S, Allhoff T, et al.
Circulation
. 2007 Sep;
116(14):1540-8.
PMID: 17848615
Background: An invasive treatment strategy improves outcome in patients with non-ST-elevation acute coronary syndrome at moderate to high risk. We hypothesized that the circulating level of growth differentiation factor 15...
8.
Wollert K, Kempf T, Peter T, Olofsson S, James S, Johnston N, et al.
Circulation
. 2007 Feb;
115(8):962-71.
PMID: 17283261
Background: Growth-differentiation factor-15 (GDF-15) is a member of the transforming growth factor-beta cytokine superfamily that is induced in the heart after ischemia-and-reperfusion injury. Circulating levels of GDF-15 may provide prognostic...